BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q1 2023

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund + Index 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB Market Price -13.34% -13.84% 5.47% -7.47% -6.68% -0.76% -1.19% 12.30% 16.46% 04/07/2010
BIB NAV -13.14% -13.92% 5.71% -7.70% -6.63% -0.77% -1.16% 12.32% 16.46% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%*
  • Gross Expense Ratio 1.08%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2023
  • NAV $52.17
  • NAV Change $+0.12 up caret
  • Market Price $0.00
  • Market Price Change $0.00
  • Trading Volume (M) 0
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount
Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%*
  • Gross Expense Ratio 1.08%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2023
  • NAV $52.17
  • NAV Change $+0.12 up caret
  • Market Price $0.00
  • Market Price Change $0.00
  • Trading Volume (M) 0
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/23.

Exposures

Index as of 12/30/2022

Holdings

as of 3/28/2023

Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
36.23% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 35,918,411 -- 8,883 --
28.73% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 28,478,371 -- 7,043 --
26.44% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 26,205,924 -- 6,481 --
13.39% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 13,274,811 -- 3,283 --
10.61% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 10,513,100 -- 2,600 --
8.89% -- NASDAQ BIO INDEX SWAP BNP 8,814,830 -- 2,180 --
6.22% REGN REGENERON PHARMACEUTICALS -- $6,163,407.41 7,453 2730190
6.05% AMGN AMGEN INC -- $6,000,872.24 25,163 2023607
5.91% GILD GILEAD SCIENCES INC -- $5,861,094.42 72,386 2369174
5.63% VRTX VERTEX PHARMACEUTICALS INC -- $5,583,368.00 17,824 2931034
3.97% MRNA MODERNA INC -- $3,935,105.28 26,784 BGSXTS3
2.89% AZN ASTRAZENECA PLC-SPONS ADR -- $2,867,137.00 41,795 2989044
2.79% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 2,761,711 -- 683 --
2.73% BIIB BIOGEN INC -- $2,707,094.25 10,017 2455965
2.65% SGEN SEAGEN INC -- $2,629,109.00 12,950 BLPK4D2
2.36% ILMN ILLUMINA INC -- $2,342,403.36 10,954 2613990
1.74% HZNP HORIZON THERAPEUTICS PLC -- $1,725,906.00 15,834 BQPVQZ6
1.64% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,622,661.30 8,606 B00FWN1
1.19% BMRN BIOMARIN PHARMACEUTICAL INC -- $1,182,502.08 12,932 2437071
1.15% RPRX ROYALTY PHARMA PLC- CL A -- $1,138,938.68 30,724 BMVP7Y0
1.13% SNY SANOFI-ADR -- $1,116,476.57 20,603 2964557
1.10% INCY INCYTE CORP -- $1,086,851.98 15,458 2471950
0.82% SRPT SAREPTA THERAPEUTICS INC -- $816,790.00 6,100 B8DPDT7
0.80% BNTX BIONTECH SE-ADR -- $797,409.00 6,483 BK6H543
0.80% VTRS VIATRIS INC -- $790,723.16 82,972 BMWS3X9
0.76% ARGX ARGENX SE - ADR -- $753,075.30 2,055 BDVLM39
0.71% UTHR UNITED THERAPEUTICS CORP -- $702,733.20 3,210 2430412
0.66% BGNE BEIGENE LTD-ADR -- $649,761.84 2,954 BYYWPW6
0.65% NBIX NEUROCRINE BIOSCIENCES INC -- $645,561.36 6,696 2623911
0.63% JAZZ JAZZ PHARMACEUTICALS PLC -- $622,449.00 4,365 B4Q5ZN4
0.52% APLS APELLIS PHARMACEUTICALS INC -- $515,681.28 7,936 BYTQ6X1
0.44% ASND ASCENDIS PHARMA A/S - ADR -- $433,174.56 3,948 BV9G6B8
0.43% KRTX KARUNA THERAPEUTICS INC -- $430,859.65 2,393 BJMLSD2
0.43% NVCR NOVOCURE LTD -- $422,356.47 7,311 BYSS4X4
0.43% EXEL EXELIXIS INC -- $421,724.36 22,468 2576941
0.39% MEDP MEDPACE HOLDINGS INC -- $390,812.56 2,153 BDCBC61
0.39% ROIV ROIVANT SCIENCES LTD -- $386,463.00 52,580 BMW4NZ9
0.37% ITCI INTRA-CELLULAR THERAPIES INC -- $365,923.18 6,566 BHCB0P4
0.36% RXDX PROMETHEUS BIOSCIENCES INC -- $361,395.60 3,295 BMZ9Z11
0.35% HALO HALOZYME THERAPEUTICS INC -- $342,646.35 9,385 2975098
0.34% IONS IONIS PHARMACEUTICALS INC -- $339,848.19 9,911 BDJ0LS6
0.31% ALKS ALKERMES PLC -- $311,024.13 11,397 B3P6D26
0.31% MDGL MADRIGAL PHARMACEUTICALS INC -- $302,685.60 1,257 BD59BS7
0.25% SYNH SYNEOS HEALTH INC -- $245,699.81 7,157 BFMZ4V6
0.24% CRSP CRISPR THERAPEUTICS AG -- $239,070.20 5,452 BDHF4K6
0.23% PTCT PTC THERAPEUTICS INC -- $230,879.04 5,117 B17VCN9
0.23% CYTK CYTOKINETICS INC -- $229,503.78 6,561 BBBSBJ5
0.23% ISEE IVERIC BIO INC -- $228,963.18 9,434 BK8Y8K9
0.22% NTLA INTELLIA THERAPEUTICS INC -- $219,794.04 6,102 BYZM6C2
0.22% FOLD AMICUS THERAPEUTICS INC -- $218,337.17 19,477 B19FQ48
0.22% DNLI DENALI THERAPEUTICS INC -- $216,242.32 9,476 BD2B4V0
0.21% LEGN LEGEND BIOTECH CORP-ADR -- $210,270.52 4,492 BMX9K07
0.21% VIR VIR BIOTECHNOLOGY INC -- $209,208.20 9,257 BK4PZ38
0.21% ACAD ACADIA PHARMACEUTICALS INC -- $207,282.21 11,247 2713317
0.21% PCVX VAXCYTE INC -- $203,592.81 5,549 BKPVGH6
0.20% ABCM ABCAM PLC-SPON ADR -- $194,839.92 14,828 BMF7DY4
0.20% RETA REATA PHARMACEUTICALS INC-A -- $194,732.00 2,225 BYY9FX8
0.19% AXSM AXSOME THERAPEUTICS INC -- $185,575.67 3,017 BYZR4X4
0.18% RARE ULTRAGENYX PHARMACEUTICAL IN -- $183,328.88 4,868 BJ62Z18
0.18% ARWR ARROWHEAD PHARMACEUTICALS IN -- $182,168.34 7,509 BYQBFJ8
0.18% RVNC REVANCE THERAPEUTICS INC -- $180,178.60 5,740 BJFSR99
0.18% BPMC BLUEPRINT MEDICINES CORP -- $177,048.63 4,159 BWY52P3
0.18% PRTA PROTHENA CORP PLC -- $175,349.28 3,644 B91XRN2
0.17% SAGE SAGE THERAPEUTICS INC -- $172,969.20 4,140 BP4GNK9
0.17% ZLAB ZAI LAB LTD-ADR -- $163,616.40 4,835 BD9GVY0
0.16% GH GUARDANT HEALTH INC -- $163,548.66 7,117 BFXC911
0.16% INSM INSMED INC -- $158,877.60 9,457 2614487
0.16% BBIO BRIDGEBIO PHARMA INC -- $157,724.82 10,494 BK1KWG8
0.16% PACB PACIFIC BIOSCIENCES OF CALIF -- $156,387.77 17,129 B4N8MH9
0.15% BEAM BEAM THERAPEUTICS INC -- $151,373.04 5,019 BK6L288
0.15% ABCL ABCELLERA BIOLOGICS INC -- $150,584.75 19,945 BL53SR3
0.15% XENE XENON PHARMACEUTICALS INC -- $150,112.32 4,336 BRJ3GY4
0.15% MRTX MIRATI THERAPEUTICS INC -- $147,036.96 4,024 BBPK0J0
0.15% PRVB PROVENTION BIO INC -- $144,838.20 6,045 BG346B3
0.14% KRYS KRYSTAL BIOTECH INC -- $141,415.48 1,786 BD6JX35
0.14% AMLX AMYLYX PHARMACEUTICALS INC -- $140,132.43 4,593 BPCK358
0.14% IMVT IMMUNOVANT INC -- $139,965.00 9,030 BJRFSB7
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $136,389.72 3,748 B72ZBG4
0.14% VTYX VENTYX BIOSCIENCES INC -- $135,560.04 3,927 BMG99Y1
0.13% RVMD REVOLUTION MEDICINES INC -- $130,310.98 6,274 BL71K91
0.13% MYGN MYRIAD GENETICS INC -- $128,146.58 5,618 2614153
0.13% HRMY HARMONY BIOSCIENCES HOLDINGS -- $127,296.40 4,133 BKSGZN7
0.13% PCRX PACIRA BIOSCIENCES INC -- $127,153.26 3,186 B3X26D8
0.13% AMPH AMPHASTAR PHARMACEUTICALS IN -- $127,069.92 3,351 BNFWZS4
0.13% RLAY RELAY THERAPEUTICS INC -- $126,225.00 8,415 BN2R582
0.13% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $125,163.20 9,136 BMCWKZ2
0.13% AKRO AKERO THERAPEUTICS INC -- $124,233.44 3,242 BK7Y2V9
0.12% FGEN FIBROGEN INC -- $122,810.49 6,529 BSDRYR8
0.12% GMAB GENMAB A/S -SP ADR -- $119,934.72 3,231 BBC9WC7
0.12% XNCR XENCOR INC -- $115,953.32 4,162 BGCYWN8
0.11% IRWD IRONWOOD PHARMACEUTICALS INC -- $113,175.33 10,687 B3MZ6K5
0.11% BCRX BIOCRYST PHARMACEUTICALS INC -- $112,228.35 13,065 2100362
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $108,625.16 9,884 BFWLC09
0.11% SWTX SPRINGWORKS THERAPEUTICS INC -- $108,195.01 4,333 BGMGM89
0.11% KYMR KYMERA THERAPEUTICS INC -- $107,701.90 3,826 BMPRZV5
0.11% PLRX PLIANT THERAPEUTICS INC -- $104,134.98 3,958 BMDWW66
0.10% KDNY CHINOOK THERAPEUTICS INC -- $103,762.45 4,565 BMWXTQ9
0.10% MORF MORPHIC HOLDING INC -- $102,568.22 2,741 BK8M4J4
0.10% VCYT VERACYTE INC -- $102,364.92 4,974 BFTWZY0
0.10% SNDX SYNDAX PHARMACEUTICALS INC -- $101,163.40 4,745 BN7Q7R7
0.10% CVAC CUREVAC NV -- $98,874.33 15,389 BN4RD42
0.10% RNA AVIDITY BIOSCIENCES INC -- $98,621.81 4,909 BMWHPY1
0.10% DICE DICE THERAPEUTICS INC -- $97,497.50 3,305 BNRPLC7
0.10% TVTX TRAVERE THERAPEUTICS INC -- $97,231.74 4,489 BLFGJD5
0.10% ARVN ARVINAS INC -- $96,571.95 3,693 BDZ30Q0
0.10% IOVA IOVANCE BIOTHERAPEUTICS INC -- $96,540.66 15,546 BF0DMK7
0.10% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $95,376.16 2,068 BLCD809
0.09% NUVL NUVALENT INC-A -- $92,077.44 3,536 BMVBZD3
0.09% ACLX ARCELLX INC -- $91,960.00 3,040 BPCJ1Q2
0.09% VRNA VERONA PHARMA PLC - ADR -- $88,444.54 4,409 BYWPZK5
0.09% LGND LIGAND PHARMACEUTICALS -- $87,177.92 1,184 2501578
0.09% RCKT ROCKET PHARMACEUTICALS INC -- $86,860.79 5,501 BDFKQ07
0.09% AGIO AGIOS PHARMACEUTICALS INC -- $86,434.15 3,833 BCBVTX1
0.09% SMMT SUMMIT THERAPEUTICS INC -- $84,647.50 48,370 BMTVQS7
0.08% ADPT ADAPTIVE BIOTECHNOLOGIES -- $81,823.20 9,930 BJ5FZ74
0.08% RXRX RECURSION PHARMACEUTICALS-A -- $81,649.56 12,718 BM9FJ13
0.08% KROS KEROS THERAPEUTICS INC -- $79,379.60 1,910 BM7V485
0.08% DCPH DECIPHERA PHARMACEUTICALS IN -- $79,027.65 5,265 BZ1LFB2
0.07% REPL REPLIMUNE GROUP INC -- $74,317.76 3,928 BDDVW37
0.07% MNKD MANNKIND CORP -- $73,370.97 18,297 BF081J4
0.07% PTGX PROTAGONIST THERAPEUTICS INC -- $71,699.22 3,411 BDCBCD8
0.07% RYTM RHYTHM PHARMACEUTICALS INC -- $67,183.20 3,906 BF2YWG4
0.07% ZNTL ZENTALIS PHARMACEUTICALS INC -- $66,935.52 3,956 BMQ5T49
0.07% GERN GERON CORP -- $65,759.68 30,304 2370381
0.07% QURE UNIQURE NV -- $65,367.99 3,257 BJFSR88
0.07% DAWN DAY ONE BIOPHARMACEUTICALS I -- $65,216.21 5,099 BLB0YH0
0.06% BMEA BIOMEA FUSION INC -- $62,586.98 2,038 BNKF6N0
0.06% BLU BELLUS HEALTH INC -- $62,267.94 8,721 BJXPS33
0.06% EQRX EQRX INC -- $61,311.94 33,874 BP0WH76
0.06% VERV VERVE THERAPEUTICS INC -- $61,288.85 4,271 BNKGXX2
0.06% KURA KURA ONCOLOGY INC -- $58,600.75 4,745 BYZD465
0.06% MIRM MIRUM PHARMACEUTICALS INC -- $58,506.84 2,556 BJDX8Y8
0.06% ETNB 89BIO INC -- $58,498.45 3,505 BK1K484
0.06% ARDX ARDELYX INC -- $58,096.74 13,767 BN89V40
0.06% CBAY CYMABAY THERAPEUTICS INC -- $57,894.48 6,564 BJ3WDH3
0.06% TWST TWIST BIOSCIENCE CORP -- $57,553.20 3,942 BGKG6G7
0.06% INBX INHIBRX INC -- $57,481.76 3,019 BK1MBC3
0.06% CRNX CRINETICS PHARMACEUTICALS IN -- $57,213.47 3,737 BDD19F8
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $57,089.54 2,362 BX7RSN3
0.06% RGNX REGENXBIO INC -- $56,734.79 3,013 BZ0G875
0.06% IMGN IMMUNOGEN INC -- $56,471.76 15,304 2457864
0.06% MRUS MERUS NV -- $56,385.16 3,211 BZBY005
0.06% ENTA ENANTA PHARMACEUTICALS INC -- $56,211.36 1,448 B9L5200
0.06% GRFS GRIFOLS SA-ADR -- $55,060.94 7,799 B8K7T65
0.05% INVA INNOVIVA INC -- $53,228.21 4,723 BDDXF67
0.05% TBPH THERAVANCE BIOPHARMA INC -- $49,408.60 4,670 BMNDK09
0.05% ALLO ALLOGENE THERAPEUTICS INC -- $49,288.56 10,018 BFZNYB7
0.05% ADMA ADMA BIOLOGICS INC -- $49,161.15 15,315 B9NSBM2
0.05% COGT COGENT BIOSCIENCES INC -- $48,799.22 4,846 BLR6XK8
0.05% MCRB SERES THERAPEUTICS INC -- $47,940.90 8,638 BYNQNP8
0.05% IBRX IMMUNITYBIO INC -- $47,688.48 28,728 BNSP0B8
0.05% ANIP ANI PHARMACEUTICALS INC -- $46,730.20 1,210 BCDWBX6
0.05% IDYA IDEAYA BIOSCIENCES INC -- $45,436.32 3,336 BK0VHF6
0.05% AVXL ANAVEX LIFE SCIENCES CORP -- $45,011.20 5,410 BYTYP72
0.04% HROW HARROW HEALTH INC -- $43,839.95 2,065 BHNDW86
0.04% ME 23ANDME HOLDING CO -CLASS A -- $43,639.24 20,018 BM9CKX3
0.04% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $43,366.40 4,235 BKX9VD3
0.04% SPRY ARS PHARMACEUTICALS INC -- $43,134.14 6,501 BMCR7V2
0.04% ANAB ANAPTYSBIO INC -- $42,573.60 1,971 BDRW1L7
0.04% RAPT RAPT THERAPEUTICS INC -- $42,083.85 2,355 BK5T6R0
0.04% SANA SANA BIOTECHNOLOGY INC -- $41,387.99 13,223 BMFJJ97
0.04% CSTL CASTLE BIOSCIENCES INC -- $40,892.40 1,842 BKLCWZ3
0.04% AMRN AMARIN CORP PLC -ADR -- $40,511.34 26,478 2301938
0.04% DYN DYNE THERAPEUTICS INC -- $40,223.82 3,614 BN15WD1
0.04% AVDL AVADEL PHARMACEUTICALS-ADR -- $40,004.07 4,353 BDTZ028
0.04% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $39,961.60 1,784 BKDQKM6
0.04% ICPT INTERCEPT PHARMACEUTICALS IN -- $39,189.15 2,871 B7N59F8
0.04% LYEL LYELL IMMUNOPHARMA INC -- $38,417.10 17,305 BN6MB18
0.04% FDMT 4D MOLECULAR THERAPEUTICS IN -- $37,553.12 2,246 BKLXFX5
0.04% ACRS ACLARIS THERAPEUTICS INC -- $37,176.96 4,624 BYV2W40
0.04% NVAX NOVAVAX INC -- $36,799.84 5,974 BJDQXG4
0.04% TERN TERNS PHARMACEUTICALS INC -- $36,698.77 3,433 BMDJ0C9
0.04% FATE FATE THERAPEUTICS INC -- $35,862.35 6,805 BCZS820
0.04% ALEC ALECTOR INC -- $35,859.88 5,756 BJ4LDC4
0.04% HLVX HILLEVAX INC -- $35,581.68 2,312 BN7SBS2
0.03% CHRS COHERUS BIOSCIENCES INC -- $34,616.64 5,392 BRK0149
0.03% ITOS ITEOS THERAPEUTICS INC -- $34,376.04 2,466 BMWXFT4
0.03% EDIT EDITAS MEDICINE INC -- $34,000.02 4,782 BZ8FPH3
0.03% GLPG GALAPAGOS NV-SPON ADR -- $33,945.00 930 B292NQ7
0.03% IGMS IGM BIOSCIENCES INC -- $32,946.20 2,020 BKS3SM8
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $32,541.00 10,847 BZ0QMB7
0.03% EOLS EVOLUS INC -- $32,010.79 3,899 BDRJH21
0.03% HCM HUTCHMED CHINA-ADR -- $31,713.00 2,325 BYXV9H7
0.03% BLUE BLUEBIRD BIO INC -- $30,823.20 7,135 BBFL7S1
0.03% MRSN MERSANA THERAPEUTICS INC -- $30,704.90 7,489 BF3NP05
0.03% EWTX EDGEWISE THERAPEUTICS INC -- $30,702.00 4,386 BKY5JZ8
0.03% LXRX LEXICON PHARMACEUTICALS INC -- $30,354.88 13,084 BWFZX59
0.03% NSTG NANOSTRING TECHNOLOGIES INC -- $28,936.48 3,244 BBL59X6
0.03% SIGA SIGA TECHNOLOGIES INC -- $28,909.73 5,063 2107437
0.03% MXCT MAXCYTE INC -- $28,866.00 7,075 BKMQF66
0.03% CGEM CULLINAN ONCOLOGY INC -- $28,568.48 2,726 BM90J52
0.03% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $28,535.50 1,841 BKC9SX3
0.03% NRIX NURIX THERAPEUTICS INC -- $28,509.90 3,277 BMVLGP2
0.03% MGNX MACROGENICS INC -- $28,342.30 4,262 BFDV8K0
0.03% KPTI KARYOPHARM THERAPEUTICS INC -- $27,581.58 7,858 BG3FZW0
0.03% RPTX REPARE THERAPEUTICS INC -- $27,186.44 2,917 BLF0CW7
0.03% WVE WAVE LIFE SCIENCES LTD -- $27,175.77 6,777 BYZG9R0
0.03% OCUL OCULAR THERAPEUTIX INC -- $27,068.73 5,339 BNZB1X8
0.03% VNDA VANDA PHARMACEUTICALS INC -- $26,732.23 3,937 B12W3P6
0.03% SRRK SCHOLAR ROCK HOLDING CORP -- $26,345.61 3,582 BFZQ0L8
0.03% ALLK ALLAKOS INC -- $26,227.08 5,907 BDD19P8
0.03% KNSA KINIKSA PHARMACEUTICALS-A -- $26,190.36 2,394 BD0MGM0
0.03% ERAS ERASCA INC -- $26,167.00 9,550 BNLYBF3
0.03% ALVR ALLOVIR INC -- $25,984.80 6,480 BL9XBL4
0.03% EGRX EAGLE PHARMACEUTICALS INC -- $25,409.34 902 BJH7VB4
0.03% OMGA OMEGA THERAPEUTICS INC -- $25,324.96 3,814 BNHQ2L6
0.02% TSVT 2SEVENTY BIO INC -- $24,213.09 2,629 BMTXV88
0.02% PETQ PETIQ INC -- $24,168.27 2,009 BDH65C8
0.02% NAUT NAUTILUS BIOTECHNOLOGY INC -- $23,200.76 8,657 BNG1NK8
0.02% TNGX TANGO THERAPEUTICS INC -- $22,984.88 6,113 BP2P6L0
0.02% ALPN ALPINE IMMUNE SCIENCES INC -- $22,981.26 3,183 BYX38M1
0.02% HUMA HUMACYTE INC -- $22,733.82 7,149 BMYTJP4
0.02% GLUE MONTE ROSA THERAPEUTICS INC -- $22,713.35 3,355 BP7KZP7
0.02% TARS TARSUS PHARMACEUTICALS INC -- $22,631.76 1,849 BMH5RL1
0.02% STOK STOKE THERAPEUTICS INC -- $21,954.02 2,734 BJQ05Z6
0.02% NGM NGM BIOPHARMACEUTICALS INC -- $21,728.16 5,688 BJ1FD63
0.02% MRNS MARINUS PHARMACEUTICALS INC -- $21,465.60 3,440 BM8MVZ3
0.02% DSGN DESIGN THERAPEUTICS INC -- $21,318.00 3,876 BMFK3H6
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $20,698.80 1,410 BL95N25
0.02% CRBU CARIBOU BIOSCIENCES INC -- $20,003.17 4,229 BNYJR68
0.02% SGMO SANGAMO THERAPEUTICS INC -- $19,857.70 11,681 2573083
0.02% GBIO GENERATION BIO CO -- $19,811.44 4,136 BMC2Z79
0.02% PHAT PHATHOM PHARMACEUTICALS INC -- $19,762.25 2,885 BJLKVS6
0.02% PRLD PRELUDE THERAPEUTICS INC -- $19,742.10 3,318 BKX8YL9
0.02% ATRA ATARA BIOTHERAPEUTICS INC -- $19,019.00 6,650 BP4WT09
0.02% PSTX POSEIDA THERAPEUTICS INC -- $18,949.62 5,959 BJ4SF41
0.02% PEPG PEPGEN INC -- $18,837.00 1,638 BMTX3D7
0.02% HLTH CUE HEALTH INC -- $18,440.80 10,360 BM9J045
0.02% CARA CARA THERAPEUTICS INC -- $18,401.50 3,725 BJ4YJ92
0.02% STRO SUTRO BIOPHARMA INC -- $18,331.00 3,985 BF12XC2
0.02% AVIR ATEA PHARMACEUTICALS INC -- $18,027.36 5,778 BLN9Z50
0.02% OMER OMEROS CORP -- $18,004.86 4,349 B4NB858
0.02% KOD KODIAK SCIENCES INC -- $17,767.40 3,626 BFXC933
0.02% CDXS CODEXIS INC -- $17,693.64 4,572 B5LL2C2
0.02% KNTE KINNATE BIOPHARMA INC -- $17,330.92 3,062 BLGZBT1
0.02% IMRX IMMUNEERING CORP - CLASS A -- $17,174.78 1,831 BMVBZF5
0.02% MGTX MEIRAGTX HOLDINGS PLC -- $16,939.44 3,361 BFYQFJ2
0.02% CMPS COMPASS PATHWAYS PLC -- $16,838.58 1,646 BMC3HS7
0.02% FHTX FOGHORN THERAPEUTICS INC -- $16,547.58 2,898 BMF7DT9
0.02% ACET ADICET BIO INC -- $16,399.92 2,971 BMC5RV6
0.02% EXAI EXSCIENTIA PLC -- $16,330.88 3,002 BP48134
0.02% OPTN OPTINOSE INC -- $15,444.00 7,722 BYZ2JT0
0.02% PMVP PMV PHARMACEUTICALS INC -- $15,386.76 3,166 BMW5084
0.02% PGEN PRECIGEN INC -- $15,376.41 17,402 BKM5C84
0.02% ATAI ATAI LIFE SCIENCES NV -- $15,295.00 11,500 BN6M8F1
0.02% KZR KEZAR LIFE SCIENCES INC -- $15,215.40 4,740 BFMLG29
0.02% ALT ALTIMMUNE INC -- $15,098.72 3,416 BFY7DC4
0.02% INO INOVIO PHARMACEUTICALS INC -- $14,893.59 17,296 BN5H5K1
0.01% IMAB I-MAB-SPONSORED ADR -- $14,855.34 4,731 BKRRKY7
0.01% GRTS GRITSTONE BIO INC -- $14,334.40 5,780 BF12XF5
0.01% IPSC CENTURY THERAPEUTICS INC -- $14,147.94 4,089 BNK9MY5
0.01% CNTA CENTESSA PHARMACEUTICALS-ADR -- $14,142.60 3,645 BLB0YQ9
0.01% ALXO ALX ONCOLOGY HOLDINGS INC -- $13,757.75 2,825 BLN7XQ1
0.01% SELB SELECTA BIOSCIENCES INC -- $13,579.52 10,609 BZB1WS8
0.01% QSI QUANTUM-SI INC -- $13,297.60 8,311 BNR5QT9
0.01% FULC FULCRUM THERAPEUTICS INC -- $13,038.75 4,275 BJDX8Z9
0.01% URGN UROGEN PHARMA LTD -- $12,824.01 1,601 BZ7PJQ1
0.01% ANNX ANNEXON INC -- $12,778.74 3,302 BMVV9R5
0.01% XERS XERIS BIOPHARMA HOLDINGS INC -- $12,539.24 9,428 BLR7H87
0.01% -- ACHILLION PHARMACEUTICALS INC COMMON STOCK USD -- $11,641.22 25,307 --
0.01% NKTX NKARTA INC -- $11,573.28 3,384 BK80YJ8
0.01% ABOS ACUMEN PHARMACEUTICALS INC -- $11,376.37 2,837 BLR8WK7
0.01% CCCC C4 THERAPEUTICS INC -- $11,325.33 3,401 BKX9NQ0
0.01% ADAP ADAPTIMMUNE THERAPEUTICS-ADR -- $10,681.62 10,077 BWY4XV3
0.01% ABSI ABSCI CORP -- $10,441.78 6,406 BN94K69
0.01% IVVD INVIVYD INC -- $10,199.25 7,555 BM8NHS1
0.01% TCRT ALAUNOS THERAPEUTICS INC -- $9,996.87 16,667 B0HZZ46
0.01% GRPH GRAPHITE BIO INC -- $9,878.40 4,032 BP7L2W6
0.01% ESPR ESPERION THERAPEUTICS INC -- $9,343.84 5,309 BBNBTD2
0.01% NKTR NEKTAR THERAPEUTICS -- $9,319.74 13,119 2454445
0.01% GTHX G1 THERAPEUTICS INC -- $9,263.76 3,509 BF0QXG9
0.01% GRCL GRACELL BIOTECHNOLOGIES-ADR -- $8,970.56 4,624 BM90J85
0.01% GOSS GOSSAMER BIO INC -- $8,253.00 6,550 BJ0CK86
0.01% BCAB BIOATLA INC -- $7,517.65 3,199 BNC5F86
0.01% AFMD AFFIMED NV -- $7,209.83 10,353 BQQF5R2
0.01% TIL INSTIL BIO INC -- $5,557.45 8,997 BLFF921
-- GRNA GREENLIGHT BIOSCIENCES HOLDI -- $4,709.24 10,507 BMC7H34
-- EIGR EIGER BIOPHARMACEUTICALS INC -- $2,720.15 3,056 BDC6XM9
-- EVLO EVELO BIOSCIENCES INC -- $1,569.19 7,599 BFMFL82
-- -- NET OTHER ASSETS (LIABILITIES) -- $26,819,807.54 26,819,808 --

Index

as of 12/30/2022

  • Total Number of Companies273
  • Price/Earnings Ratio--
  • Price/Book Ratio4.174
  • Dividend Yield ( % )0.75
  • Avg. Index Market Capitalization$5.60 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series Research & Insights

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This leveraged ProShares ETF seeks a return that is 2x the return of its underlying benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, holding periods of greater than one day can result in returns that are significantly different than the target return, and ProShares' returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks. Investors should monitor their holdings as frequently as daily. Investors should consult the prospectus for further details on the calculation of the returns and the risks associated with investing in this product.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares ETFs (ProShares Trust and ProShares Trust II) are distributed by SEI Investments Distribution Co., which is not affiliated with the funds' advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.